Evidence map›Paper›PMID 29311905›Full record

ArticleFrontiers in aging neuroscience2017

Sachchida N Rai, Hareram Birla, Saumitra S Singh, Walia Zahra, Ravishankar R Patil, Jyoti P Jadhav, Mallikarjuna R Gedda, Surya P Singh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Phytochemicals of Biologically Active Fractions fromCurrent topics in medicinal chemistry · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Evaluating the neuroprotective potential ofIn silico pharmacology · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. 3 Biotech · 2024
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sachchida N RaiDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Hareram BirlaDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Saumitra S SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Walia ZahraDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Ravishankar R PatilDepartment of Biotechnology, Shivaji University, Kolhapur, India.
Jyoti P JadhavDepartment of Biotechnology, Shivaji University, Kolhapur, India.
Mallikarjuna R GeddaDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Surya P SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Banaras Hindu University · INShivaji University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Till date, drugs that have been used to manage Parkinson's disease (PD) have only shown symptomatic relief with several adverse effects besides their inability to prevent neurodegeneration. Neuroinflammation plays an important role in the advancement of PD and can be targeted for its effective treatment. Researchers have suggested that herbal plants exhibiting the anti-inflammatory and anti-oxidant properties are therefore beneficial to human health. Conventionally,

Indexed as

236-tetrahydropyridine)MPTP (1-methyl-4-phenyl-1Mucuna pruriensneuroinflammationParkinson’s diseasesubstantia nigratyrosine hydroxylase

Identifiers

PMID29311905
PMCPMC5742110
OpenAlexW2775885880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.